Wexford Capital’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-100,000
Closed -$213K 256
2025
Q1
$213K Buy
100,000
+80,000
+400% +$170K 0.06% 181
2024
Q4
$63.8K Buy
+20,000
New +$63.8K 0.01% 201